Is T2 Biosystems Inc (NASDAQ:TTOO) being unfairly punished by investors?

The price of T2 Biosystems Inc (NASDAQ:TTOO) shares last traded on Wall Street fell -31.07% to $0.13.

TTOO stock price is now -61.49% away from the 50-day moving average and -94.78% away from the 200-day moving average. The market capitalization of the company currently stands at $3.76M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target reduced from $2.60 to $2.40, Alliance Global Partners Downgraded its rating from Buy to Neutral for T2 Biosystems Inc (NASDAQ: TTOO). On October 08, 2020, BTIG Research recently initiated its ‘Buy’ rating on the stock quoting a target price of $2.50, while ‘Janney’ rates the stock as ‘Neutral’

In other news, Elsbree David B, Director sold 55 shares of the company’s stock on Sep 13 ’24. The stock was sold for $133 at an average price of $2.42. Upon completion of the transaction, the Director now directly owns 23 shares in the company, valued at $2.99. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 13 ’24, Director Elsbree David B bought 55 shares of the business’s stock. A total of $132 was incurred on buying the stock at an average price of $2.41. A total of 55.51% of the company’s stock is owned by insiders.

During the past 12 months, T2 Biosystems Inc has had a low of $0.18 and a high of $6.95. The fifty day moving average price for TTOO is $0.35494 and a two-hundred day moving average price translates $2.5799 for the stock.

The latest earnings results from T2 Biosystems Inc (NASDAQ: TTOO) was released for 2024-06-30. The company reported revenue of $1.99 million for the quarter, compared to $1.47 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 34.85 percent.

Related Posts